Compare use cases

Drop two or three slugs into the URL — for example ?slugs=demo-mia-breast-screening,demo-idx-dr-retinopathy — or pick from the validated catalogue below.

Pick from validated:

AI imaging triage for the acute stroke pathway AI second reader for breast cancer screening Autonomous diabetic retinopathy screening in primary care Pre-operative risk-stratification model for major surgery Self-referral assistant for NHS Talking Therapies Type-2 diabetes long-term outcome predictor

Clear selection

	Type-2 diabetes long-term outcome predictor Netherlands	AI second reader for breast cancer screening United Kingdom	AI imaging triage for the acute stroke pathway United Kingdom
Trust badge	Validated	Validated	Validated & replicable
Evidence strength	Robust evidence	Emerging evidence	Developing evidence
Pipeline stage	Validated	Validated	Scaled
Intended use	Estimates 5-year risk of major diabetes-related complications (cardiovascular, renal, retinal) from longitudinal primary-care records to support care-plan intensification.	Acts as an independent second reader of screening mammograms to support the double-reading workflow and reduce reader workload without lowering cancer detection.	Interprets acute stroke imaging to support rapid identification of large-vessel occlusion and treatment eligibility, accelerating thrombectomy referral.
Specialty	Endocrinology	Radiology	Emergency medicine
Autonomy	Informs a human (advisory)	Informs a human (advisory)	Informs a human (advisory)
Deployment	Active deployment	Active deployment	Scaling up
EU AI Act tier	High-risk	High-risk	High-risk
EU MDR class	Not a device	Class IIb	Class IIb
CE marking	Not required	CE marked	CE marked
NICE ESF tier	Tier C — treat / diagnose / calculate risk	Tier C — treat / diagnose / calculate risk	Tier C — treat / diagnose / calculate risk
Headline metric	AUC / AUROC: 0.82	Sensitivity: 0.91	Time saved: 60
Subgroup assessed	Yes	Yes	Yes